⏳ Fetching live dividend data...
Home › Calculator › YIHCF Dividend Calculator 2026
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. · OTC
Price: $0.55 · Annual div: $0.19/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in YIHCF → $537.06 in 10 years · $0.64/month
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a Chinese pharmaceutical enterprise primarily engaged in the development, manufacturing, and distribution of medicinal products. Operating within the People's Republic of China, its therapeutic expertise spans antiviral treatments, solutions for endocrine and metabolic disorders, and cardiovascular health. In addition to finished pharmaceuticals, the company produces and markets active pharmaceutical ingredients (APIs) and dedicates resources to the research and development of medical devices, novel drugs, and biotechnology. It also extends its services to include medical consulting. The company's products reach hospitals and other healthcare institutions through an established network of distributors. YiChang HEC ChangJiang Pharmaceutical has forged strategic alliances with several prominent entities, including a cooperation framework agreement with Alibaba Health Technology (China) Limited for specialized influenza projects. Other key partners encompass Jointown Pharmaceutical Group Co., Ltd., Guangdong Yihao Pharmaceutical Co., Ltd., Shenzhen HEC Industrial Development Co., Ltd., and China National Accord Medicines Corporation Ltd. Founded in Yichang, China, in 2001, the company was originally known as Yichang Changjiang Pharmaceutical Company Limited before its rebranding to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015. It operates as a subsidiary under the umbrella of Guangdong HEC Technology Holding Co., Ltd.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open YIHCF position with:
Real after-tax yield depends on where you live and how you hold YIHCF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 34.75% | 31.95% | $3,475 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 29.54% | 26.74% | $2,954 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 27.80% | 25.00% | $2,780 / yr |
| 🇬🇧 UK ISA | 0% | 34.75% | 31.95% | $3,475 / yr |
| 🇬🇧 UK Taxable | 8.75% | 31.71% | 28.91% | $3,171 / yr |
| 🇨🇦 TFSA | 0% | 34.75% | 31.95% | $3,475 / yr |
| 🇨🇦 CA Taxable | 25% | 26.06% | 23.26% | $2,606 / yr |
| 🇦🇺 Super (pension) | 15% | 29.54% | 26.74% | $2,954 / yr |
| 🇦🇺 AU Taxable | 30% | 24.32% | 21.52% | $2,433 / yr |
| 🇩🇪 DE Taxable | 26.375% | 25.58% | 22.78% | $2,558 / yr |
| 🇫🇷 FR Taxable | 30% | 24.32% | 21.52% | $2,433 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.19/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
YIHCF pays quarterly — 4 times per year. Next ex-div: TBD.
How YIHCF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for YIHCF sourced from FMP /financial-growth endpoint — real data, not estimates.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the YIHCF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (YIHCF) is currently trading at $0.55, trading near its 52-week high. The current dividend yield is 34.75% based on an annual payout of $0.19 per share.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (YIHCF) is a healthcare stock currently trading at $0.55 with a dividend yield of 34.75%. The company pays an annual dividend of $0.19 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, YIHCF has grown its dividend at a compound annual rate of 50.0%.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →